[artículo] 
inThe British Journal of Psychiatry > Año 2019 - Vol. 214 - No.2 (Febrero) . - pp. 83-89

Título :	Clozapine is associated with secondary antibody deficiency
Tipo de documento:	texto impreso
Autores:	Mark Ponsford, Autor ; Daniel Castle, Autor ; Tayyeb Tahir, Autor
Fecha de publicación:	2019
Artículo en la página:	pp. 83-89
Idioma :	Inglés (eng)
Palabras clave:	Clozapina, Esquizofrenia, Neumonía, vacunación, Deficiencia de anticuerpos secundarios
Resumen:	Schizophrenia affects 1% of the population. Clozapine is the only medication licensed for treatment-resistant schizophrenia and is intensively monitored to prevent harm from neutropenia. Clozapine is also associated with increased risk of pneumonia although the mechanism is poorly understood.
Link:	./index.php?lvl=notice_display&id=20526

[artículo] Clozapine is associated with secondary antibody deficiency [texto impreso] / Mark Ponsford, Autor ; Daniel Castle, Autor ; Tayyeb Tahir, Autor . - 2019 . - pp. 83-89.
Idioma : Inglés (eng)
in The British Journal of Psychiatry > Año 2019 - Vol. 214 - No.2 (Febrero) . - pp. 83-89

Palabras clave:	Clozapina, Esquizofrenia, Neumonía, vacunación, Deficiencia de anticuerpos secundarios
Resumen:	Schizophrenia affects 1% of the population. Clozapine is the only medication licensed for treatment-resistant schizophrenia and is intensively monitored to prevent harm from neutropenia. Clozapine is also associated with increased risk of pneumonia although the mechanism is poorly understood.
Link:	./index.php?lvl=notice_display&id=20526